Recap: Aprea Therapeutics Q1 Earnings

Aprea Therapeutics APRE reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Aprea Therapeutics beat estimated earnings by 5.26%, reporting an EPS of $-0.36 versus an estimate of $-0.38.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 14.37% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Aprea Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.